![Eric Hyllengren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Hyllengren
Directeur Financier/CFO chez
TENAYA THERAPEUTICS, INC.
Fortune : 156 791 $ au 31/08/2026
Profil
Eric Hyllengren is currently Chief Financial & Accounting Officer at Tenaya Therapeutics, Inc. since 2026.
Formerly, Mr. Hyllengren was Chief Financial & Accounting Officer at Zura Bio Ltd. from 2025 to 2026, Chief Financial, Operating & Accounting Officer at Atara Biotherapeutics, Inc. from 2024 to 2025, and Executive Director-Business Development at Amgen, Inc. from 2017 to 2018.
Mr. Hyllengren completed undergraduate studies at the University of Notre Dame and earned an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/03/2026 | 17 617 ( 0,18% ) | 156 791 $ | 31/08/2026 |
Postes actifs de Eric Hyllengren
| Sociétés | Poste | Début |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Directeur Financier/CFO | 13/07/2026 |
Anciens postes connus de Eric Hyllengren
| Sociétés | Poste | Fin |
|---|---|---|
| ZURA BIO LIMITED | Directeur Financier/CFO | 20/04/2026 |
| ATARA BIOTHERAPEUTICS, INC. | Directeur Financier/CFO | 31/03/2025 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2018 |
Formation de Eric Hyllengren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
